CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2821
+0.0020 (0.71%)
Sep 19, 2025, 3:47 PM EDT
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $367.01 million as of September 19, 2025. Its market cap has increased by 90.42% in one year.
Market Cap
367.01M
Enterprise Value
382.44M
Revenue
n/a
Ranking
n/a
PE Ratio
160.53
Stock Price
$0.28
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 367.01M, an increase of 6,527.60%. That is a compound annual growth rate of 23.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 352.05M | 161.49% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | 3.21B | 695.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Tian'an Technology Group | 719.18M |
| Elite Pharmaceuticals | 697.08M |
| Glass House Brands | 575.59M |
| Northwest Biotherapeutics | 378.51M |
| Nika Pharmaceuticals | 370.64M |
| American Oncology Network | 340.34M |
| Silence Therapeutics | 237.59M |